Literature DB >> 21958591

Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia.

Sayuri Sukigara1, Wen-Chen Liang, Hirofumi Komaki, Tokiko Fukuda, Takeshi Miyamoto, Takashi Saito, Yoshiaki Saito, Eiji Nakagawa, Kenji Sugai, Yukiko K Hayashi, Hideo Sugie, Masayuki Sasaki, Ichizo Nishino.   

Abstract

Muscle glycogen storage disease 0 (GSD0) is caused by glycogen depletion in skeletal and cardiac muscles due to deficiency of glycogen synthase 1 (GYS1), which is encoded by the GYS1 gene. Only two families with this disease have been identified. We report a new muscle GSD0 patient, a Japanese girl, who had been suffering from recurrent attacks of exertional syncope accompanied by muscle weakness and pain since age 5 years until she died of cardiac arrest at age 12. Muscle biopsy at age 11 years showed glycogen depletion in all muscle fibers. Her loss of consciousness was gradual and lasted for hours, suggesting that the syncope may not be simply caused by cardiac event but probably also contributed by metabolic distress.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958591     DOI: 10.1016/j.nmd.2011.08.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

Review 1.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1.

Authors:  H Orhan Akman; Yavuz Aykit; Ozge Ceren Amuk; Edoardo Malfatti; Norma B Romero; Maria Antonietta Maioli; Rachele Piras; Salvatore DiMauro; Gianni Marrosu
Journal:  Neuromuscul Disord       Date:  2015-11-10       Impact factor: 4.296

Review 3.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

4.  Anesthetic Management for an Adult With Glycogen Storage Disease Type 0.

Authors:  Airi Sakamizu; Erika Yaguchi; Shinsuke Hamaguchi
Journal:  Anesth Prog       Date:  2020-12-01

Review 5.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

Review 6.  Progress and challenges of gene therapy for Pompe disease.

Authors:  Giuseppe Ronzitti; Fanny Collaud; Pascal Laforet; Federico Mingozzi
Journal:  Ann Transl Med       Date:  2019-07

Review 7.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

Review 8.  Links between autophagy and disorders of glycogen metabolism - Perspectives on pathogenesis and possible treatments.

Authors:  Benjamin L Farah; Paul M Yen; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2019-11-21       Impact factor: 4.797

9.  Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.

Authors:  Saija Ahonen; Silvia Nitschke; Tamar R Grossman; Holly Kordasiewicz; Peixiang Wang; Xiaochu Zhao; Dikran R Guisso; Sahba Kasiri; Felix Nitschke; Berge A Minassian
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

Review 10.  Pompe disease: from pathophysiology to therapy and back again.

Authors:  Jeong-A Lim; Lishu Li; Nina Raben
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.